Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Martinique Science Reporter.
Press releases published on July 16, 2025
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Quebec, July 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, is …
DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Québec, 16 juill. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un leader canadien de l'intelligence artificielle (IA) pour la détection précoce des maladies …
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
GlobeNewswire
·
July 16, 2025
LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive …
Global Cryptocurrency Payment Apps Market Projected to Reach $2.4 Billion By 2033 as Demand Rises
GlobeNewswire
·
July 16, 2025
PALM BEACH, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a growing demand for cryptocurrency payments applications. A report from Grand View Research projected that the global cryptocurrency payment apps …
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
GlobeNewswire
·
July 16, 2025
SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U …
Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
GlobeNewswire
·
July 16, 2025
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, …
Silexion Therapeutics Announces 1-for-15 Reverse Share Split
GlobeNewswire
·
July 16, 2025
Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Enovix to Release Q2 2025 Financial Results on July 31
GlobeNewswire
·
July 16, 2025
FREMONT, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today announced it will release financial results for the second quarter of 2025 on Thursday, July 31, …
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
GlobeNewswire
·
July 16, 2025
SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufacturing agreement with Sterling …
Bullet Blockchain Announces Partnership and Licensing Agreement
GlobeNewswire
·
July 16, 2025
LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- Bullet Blockchain, Inc. (OTC: BULT) (“Bullet Blockchain” or the “Company”), the only U.S. company holding foundational patents for Bitcoin ATMs and one of only three publicly traded Bitcoin ATM network owner/ …
Aware Sets Second Quarter 2025 Webcast for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time
GlobeNewswire
·
July 16, 2025
BURLINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a leading global biometrics company, will hold a webcast on Wednesday, July 30, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended …
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
GlobeNewswire
·
July 16, 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global distribution …
Inspired to Report Second Quarter 2025 Results and Hold Conference Call on August 6
GlobeNewswire
·
July 16, 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. ("Inspired" or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, announced that it will report financial results for the …
Thrive Appoints Nicholas J. Smolansky as Chief Legal Officer
GlobeNewswire
·
July 16, 2025
BOSTON, July 16, 2025 (GLOBE NEWSWIRE) -- Thrive, a global technology outsourcing provider for cybersecurity, Cloud, and IT managed services, today named Nicholas J. Smolansky as Chief Legal Officer (CLO). As the company continues to expand its leadership …
CISO Global Doubles 2025 anticipated Software Bookings to $10 Million with Nationwide Launch
GlobeNewswire
·
July 16, 2025
Targeting $2 Billion Market Scottsdale, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ: CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced an increased anticipated software-related bookings of …
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
GlobeNewswire
·
July 16, 2025
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic …
Michael Gord Joins Alpha Liquid Terminal as Advisor to Drive Global Expansion and Capital Market Integration
GlobeNewswire
·
July 16, 2025
New York, NY, July 16, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid Terminal (ALTx), a next-generation modular trading platform powered by AI agents, proudly announces the appointment of Michael Gord, Founder and CEO of GDA Capital, has joined as Advisor. Gord …
Full Alliance Group Launches Development of YAHBEE SHOPPING NETWORK — A Web3-Driven, Peer-to-Peer Commerce Revolution
GlobeNewswire
·
July 16, 2025
TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), through its majority-owned subsidiary Qubitera Holdings, proudly announces the launch of the YAHBEE SHOPPING NETWORK — a groundbreaking platform that …
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
GlobeNewswire
·
July 16, 2025
PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has received a letter from the Nasdaq Hearings Panel …
CareCloud to Announce Second Quarter 2025 Results on August 5, 2025
GlobeNewswire
·
July 16, 2025
SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, …